Global Dried Blood Spot Collection Cards Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Application;
Application Market Share Analysis, Segment Dashboard, Global Dried Blood Spot Collection Cards Market, Market Size & Forecasts and Trend Analyses, Newborn Screening, Infectious Disease Testing, Therapeutic Drug Monitoring, Forensics, and Other Applications.By Card Type;
Card Type Market Share Analysis, Segment Dashboard, Whatman, Ahlstrom, FTA, and Other Card Type.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Dried Blood Spot Collection Cards Market (USD Million), 2021 - 2031
In the year 2024, the Global Dried Blood Spot Collection Cards Market was valued at USD 310.21 million. The size of this market is expected to increase to USD 413.19 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.2%.
Dried blood spot (DBS) collection cards have revolutionized the field of medical diagnostics by offering a convenient and cost-effective method for sampling and preserving blood specimens. These cards allow for the collection, transportation, and storage of blood samples in a dried format, which simplifies logistical challenges associated with traditional venous blood collection methods. The global market for dried blood spot collection cards has witnessed significant growth, driven by their widespread adoption in various applications such as clinical research, therapeutic drug monitoring, infectious disease screening, and newborn screening programs.
Advantages of DBS cards include their ability to facilitate remote sampling and easy shipment, making them particularly valuable in resource-limited settings where access to centralized laboratory facilities is limited. Moreover, DBS cards reduce the need for phlebotomy, offering a less invasive and more patient-friendly approach to blood sampling. As healthcare systems worldwide continue to emphasize personalized medicine and decentralized diagnostic solutions, the demand for dried blood spot collection cards is expected to expand, supported by advancements in analytical techniques and increasing adoption across diverse medical disciplines.
Global Dried Blood Spot Collection Cards Market Recent Developments
-
In August 2022, Boston Heart Diagnostics Corporation launched a broad range of tests with a dried blood spot collection for a broad range of applications including cardiovascular risk factors, type 2 diabetes, and wellness assessments for cognitive, nutritional, women's, and men's health.
-
In June 2022, a group of researchers from the Division of Vector-Borne Diseases, Fort Collins, conducted a study to assess the use of Whatman FTA cards in molecular diagnostics for the detection of Yellow Fever Virus (YFV). The study showed that the card can be easy to use and cost-effective in the molecular diagnosis of yellow fever. Furthermore, it allows the physician to preserve viral RNA without a cold chain.
Segment Analysis
The Global Dried Blood Spot (DBS) Collection Cards Market has been segmented by Application, Card Type, and Geography, offering insights into the growing demand for DBS technology across various industries, including healthcare, diagnostics, and research. These segments highlight the diverse applications of DBS collection cards, their different types, and the regional dynamics that influence their adoption.
By Application, the DBS collection cards market is divided into Neonatal Screening, Infectious Disease Testing, Therapeutic Drug Monitoring, Toxicology Testing, and Other Applications. Neonatal Screening is the largest application segment, as DBS collection cards are widely used for screening newborns for metabolic and genetic disorders. Infectious Disease Testing is another significant application, where DBS cards are used to diagnose infections like HIV, hepatitis, and malaria, especially in resource-limited settings where traditional blood collection methods are not feasible. Therapeutic Drug Monitoring and Toxicology Testing utilize DBS cards for monitoring drug levels and detecting substances such as drugs, alcohol, or toxins in the blood, offering a minimally invasive and cost-effective method for routine testing.
By Card Type, the market is segmented into Standard DBS Cards and Specialized DBS Cards. Standard DBS Cards are typically used for general applications like neonatal screening and infectious disease testing, as they offer reliable and cost-effective blood sample collection and transport. Specialized DBS Cards, on the other hand, are designed for more specific applications, such as monitoring therapeutic drugs or conducting research on biomarkers. These cards may feature advanced materials or unique designs that improve sample stability, sensitivity, or ease of handling. The choice of card type depends on the clinical requirements, with specialized cards seeing increasing demand in research and precision medicine, where high levels of accuracy and quality are necessary.
Geographically, the Global Dried Blood Spot Collection Cards Market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds the largest market share, driven by the high adoption of DBS technology in healthcare and diagnostics, alongside well-established neonatal screening programs. Europe follows with strong growth, fueled by advancements in healthcare infrastructure and increasing governmental support for newborn screening and public health initiatives. The Asia-Pacific region is expected to witness the fastest growth due to rising healthcare investments, increasing awareness of diagnostic solutions, and the expansion of healthcare access in emerging economies. Latin America and Middle East & Africa are also witnessing significant growth in the DBS collection card market, as these regions improve healthcare access and implement more cost-effective diagnostic solutions.
Global Dried Blood Spot Collection Cards Market Analysis
The Global Dried Blood Spot Collection Cards Market has been segmented by Application, Card Type and Geography.
Global Dried Blood Spot Collection Cards Market , Segmentation by Application
The Global Dried Blood Spot Collection Cards Market has been segmented by Application into Application Market Share Analysis, Segment Dashboard, Global Dried Blood Spot Collection Cards Marke, Market Size & Forecasts and Trend Analyses, Newborn Screening, Infectious Disease Testing, Therapeutic Drug Monitoring, Forensics and Other Applications.
The global dried blood spot (DBS) collection cards market is segmented by various applications, each contributing uniquely to its growth trajectory. Newborn screening holds a significant portion of the market share, driven by the increasing adoption of DBS cards in early detection programs for genetic disorders and metabolic conditions. Governments and healthcare organizations worldwide are implementing comprehensive newborn screening initiatives, boosting the demand for DBS cards due to their practicality in remote and centralized testing settings.
Infectious disease testing is another pivotal application area for DBS cards, facilitating efficient sample collection, storage, and transport for diagnosing diseases such as HIV, hepatitis, and malaria. The cards' ability to simplify specimen handling and reduce biohazard risks is crucial in epidemiological studies and outbreak investigations. Moreover, therapeutic drug monitoring benefits from DBS technology, enabling precise measurement of drug levels in patients' blood over time. This application is particularly valuable in personalized medicine, ensuring optimal drug dosing and minimizing adverse effects. DBS cards also find applications in forensic investigations, facilitating the analysis of blood samples in legal and criminal justice contexts. As these diverse applications continue to evolve, the global DBS market is poised for robust growth, supported by ongoing advancements in analytical techniques and expanding healthcare access worldwide.
Global Dried Blood Spot Collection Cards Market , Segmentation by Card Type
The Global Dried Blood Spot Collection Cards Market has been segmented by Card Type into Card Type Market Share Analysis, Segment Dashboard, Whatman, Ahlstrom, FTA and Other Card Type.
The global dried blood spot (DBS) collection cards market encompasses various types of cards, each playing a significant role in sample collection and analysis across different applications. Market leaders such as Whatman and Ahlstrom hold substantial shares due to their established reputations for producing high-quality DBS cards that meet stringent industry standards. These cards are favored for their superior performance in preserving blood samples for extended periods while maintaining sample integrity and stability, critical for accurate diagnostic testing and research purposes.
Additionally, brands like FTA (Flinders Technology Associates) contribute significantly to the market, offering specialized DBS cards known for their advanced technologies such as chemically treated papers that enhance sample quality and ease of use in laboratory settings. Other types of DBS cards also play a crucial role, catering to specific needs in research, clinical trials, and public health initiatives. As the demand for reliable, cost-effective sample collection methods continues to rise across healthcare sectors and academic research institutions, the market for DBS collection cards is expected to expand, driven by ongoing advancements in card technology and increasing adoption in both developed and emerging markets globally.
Global Dried Blood Spot Collection Cards Market, Segmentation by Geography
The Global Dried Blood Spot Collection Cards Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Dried Blood Spot Collection Cards Market Share (%), by Geographical Region, 2024
The global dried blood spot (DBS) collection cards market shows varying dynamics across different regions, each contributing uniquely to its overall growth. North America and Europe lead the market due to well-established healthcare infrastructures and significant investments in medical research. These regions benefit from widespread adoption of DBS cards in clinical diagnostics, research studies, and pharmaceutical trials, driven by favorable regulatory environments and robust healthcare spending. Moreover, advancements in healthcare technologies and increasing emphasis on personalized medicine further propel market expansion in these regions.
Asia Pacific emerges as a rapidly growing market for DBS collection cards, fueled by expanding healthcare access, rising prevalence of chronic diseases, and increasing adoption of point-of-care testing solutions. Countries like China, India, and Japan are witnessing substantial investments in healthcare infrastructure and research capabilities, boosting the demand for DBS cards across clinical and research applications. In contrast, the Middle East, Africa, and Latin America regions are experiencing gradual adoption of DBS technology, influenced by improving healthcare systems, growing awareness about diagnostic advancements, and initiatives to enhance healthcare outcomes through efficient diagnostic methods. As these regions continue to strengthen their healthcare capabilities, the demand for DBS collection cards is expected to grow, supported by efforts to improve disease management and public health initiatives.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Dried Blood Spot Collection Cards Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Convenience in Sample Collection
- Logistics and Shipping Efficiency
- Minimized Biohazard Risks
-
Increasing Demand for Point-of-Care Testing: The global dried blood spot (DBS) collection cards market is experiencing a significant uptick in demand, driven primarily by the increasing adoption of point-of-care testing (POCT) solutions worldwide. POCT offers several advantages, including rapid diagnostic results, reduced turnaround times, and enhanced patient convenience, making it particularly valuable in settings where immediate clinical decisions are crucial. DBS cards play a pivotal role in POCT by simplifying the collection, storage, and transportation of blood samples, thereby facilitating decentralized testing in various healthcare settings.
The rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and infectious diseases is further bolstering the demand for POCT solutions using DBS cards. These cards enable healthcare providers to conduct diagnostic tests outside traditional laboratory environments, such as in clinics, emergency rooms, and remote or resource-limited settings. Moreover, advancements in DBS technology, including improved sample stability and analytical sensitivity, are enhancing the reliability and accuracy of POCT results. As healthcare systems globally strive to improve patient outcomes and reduce healthcare costs, the integration of DBS collection cards in POCT workflows is expected to continue expanding, catering to the growing demand for accessible and efficient diagnostic solutions.
Restraints:
- Variability in Sample Quality
- Limited Volume of Blood Collection
- Potential Hematocrit Interference
-
Challenges in Analytical Sensitivity: One of the significant challenges facing the global dried blood spot (DBS) collection cards market is maintaining adequate analytical sensitivity in diagnostic and research applications. DBS cards are designed to preserve small volumes of blood samples dried onto filter paper, which can sometimes result in lower analyte concentrations compared to traditional liquid blood samples. This lower concentration can pose challenges for analytical methods that require high sensitivity, such as detecting low-abundance biomarkers or accurately measuring drug levels in therapeutic drug monitoring. Ensuring consistent and reliable results across different analytes and concentrations remains a critical concern for stakeholders in clinical laboratories and research settings using DBS cards.
Factors such as hematocrit levels (the proportion of red blood cells in whole blood) can affect the accuracy and reproducibility of analytical results from DBS samples. Variations in hematocrit levels among individuals can impact the distribution of analytes within DBS samples, leading to potential biases in test outcomes. Addressing these challenges requires ongoing advancements in analytical techniques, assay methodologies, and DBS card technologies to improve sensitivity, precision, and robustness. As the demand for DBS collection cards continues to grow across diverse medical and research applications, overcoming these analytical sensitivity challenges will be crucial for maintaining their relevance and effectiveness in modern diagnostic and healthcare practices.
Opportunities:
- Expansion in Newborn Screening Programs
- Growing Applications in Therapeutic Drug Monitoring
- Increasing Demand in Infectious Disease Screening
-
Adoption in Biomarker Discovery and Validation: The global dried blood spot (DBS) collection cards market is increasingly recognized for its pivotal role in biomarker discovery and validation, revolutionizing how researchers and clinicians approach disease diagnosis and treatment monitoring. DBS cards offer a practical solution for collecting and storing blood samples, preserving biomarkers that can be crucial in identifying disease indicators, monitoring treatment efficacy, and predicting patient outcomes. This capability is particularly valuable in personalized medicine, where biomarkers serve as essential tools for tailoring therapies to individual patient profiles.
In biomedical research, DBS cards enable efficient sample collection from large study populations, supporting epidemiological studies, clinical trials, and longitudinal research projects. They facilitate the analysis of biomarkers associated with various diseases such as cancer, cardiovascular disorders, infectious diseases, and metabolic conditions. DBS technology also enhances the feasibility of biomarker studies in resource-limited settings and remote locations, where traditional blood collection and transportation methods may be impractical. As advancements in analytical techniques and biomarker identification continue to evolve, the adoption of DBS collection cards is expected to expand further, driving innovation in precision medicine and accelerating the translation of biomarker discoveries into clinical applications.
Competitive Landscape Analysis
Key players in Global Dried Blood Spot Collection Cards Market include:
- F. Hoffmann-La Roche Ltd
- QIAGEN
- Shimadzu Scientific Instruments
- Eastern Business Forms, Inc
- Ahlstrom-Munksjö
- PerkinElmer
- ARCHIMEDlife
- CENTOGENE N.V
- Hemaxis
- Lipomic Healthcare
- Gentegra LLC
- Thomas Scientific
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Card Type
- Market Snapshot, By Region
- Global Dried Blood Spot Collection Cards Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Convenience in Sample Collection
-
Logistics and Shipping Efficiency
-
Minimized Biohazard Risks
-
Increasing Demand for Point-of-Care Testing
-
- Restraints
-
Variability in Sample Quality
-
Limited Volume of Blood Collection
-
Potential Hematocrit Interference
-
Challenges in Analytical Sensitivity
-
- Opportunities
-
Expansion in Newborn Screening Programs
-
Growing Applications in Therapeutic Drug Monitoring
-
Increasing Demand in Infectious Disease Screening
-
Adoption in Biomarker Discovery and Validation
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Dried Blood Spot Collection Cards Market, By Application, 2021 - 2031 (USD Million)
- Application Market Share Analysis
- Segment Dashboard
- Global Dried Blood Spot Collection Cards Marke
- Market Size & Forecasts and Trend Analyses
- Newborn Screening
- Infectious Disease Testing
- Therapeutic Drug Monitoring
- Forensics
- Global Dried Blood Spot Collection Cards Market, By Card Type, 2021 - 2031 (USD Million)
- Card Type Market Share Analysis
- Segment Dashboard
- Whatman
- Ahlstrom
- FTA
- Global Dried Blood Spot Collection Cards Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Dried Blood Spot Collection Cards Market, By Application, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- F. Hoffmann-La Roche Ltd
- QIAGEN
- Shimadzu Scientific Instruments
- Eastern Business Forms, Inc
- Ahlstrom-Munksjö
- PerkinElmer
- ARCHIMEDlife
- CENTOGENE N.V
- Hemaxis
- Lipomic Healthcare
- Gentegra LLC
- Thomas Scientific
- Company Profiles
- Analyst Views
- Future Outlook of the Market